Saglam, A. S. Et Al. 2016. Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.. Human & experimental toxicology , vol.35, no.5 , 526-43.

Saglam, A. S., Alp, E., Elmazoglu, Z., & Menevse, S., (2016). Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.. Human & experimental toxicology , vol.35, no.5, 526-43.

Saglam, ATİYE Et Al. "Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.," Human & experimental toxicology , vol.35, no.5, 526-43, 2016

Saglam, ATİYE S. Et Al. "Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.." Human & experimental toxicology , vol.35, no.5, pp.526-43, 2016

Saglam, A. S. Et Al. (2016) . "Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.." Human & experimental toxicology , vol.35, no.5, pp.526-43.

@article{article, author={ATİYE SEDA YAR SAĞLAM Et Al. }, title={Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.}, journal={Human & experimental toxicology}, year=2016, pages={526-43} }